Can a sedative keep older Patients' minds clear after knee surgery?
NCT ID NCT05707741
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This pilot trial investigates whether the sedative drug dexmedetomidine can prevent postoperative delirium—a state of confusion and altered awareness—in older adults undergoing total knee replacement under spinal anesthesia. Researchers will compare two different doses of the drug against a placebo in 45 patients aged 65 to 75. The goal is to see if this approach can safely reduce the risk of delirium after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexmedetomidine
- What this could lead to
- If effective, this could point toward a simple way to reduce confusion and delirium after surgery in older adults.
- What could go wrong
- This is a small pilot study, so results may not be definitive. The drug may not prevent delirium and could have side effects like low blood pressure or slow heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
Jun 2023
- Finished
-
Feb 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA physical status I- II * Age from 65to 75 years old, * Elective total knee arthroplasty under spinal anaesthesia. Exclusion Criteria: * Bleeding disorders * Allergy to any of the drugs used in the study * Renal insufficiency * Liver failure-Neurological abnormalities -patients with hearing and visual impairment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postoperative delirium are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Menoufia University
Menoufia, Menoufia, 32817, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effect of intrathecal dexmedetomidine as an adjuvant to hyperbaric bupivacaine on the incidence of postoperative delirium in elderly patients undergoing hip fracture surgeries under spinal anesthesia
- Could a sleep drug shield older hearts from post-surgery delirium?
- Could a common sedative shield aging brains from Post-Surgery delirium?
- Brain surgery for Parkinson's: can we foresee the confusion that follows?
- A simple care plan may shield older brains after surgery
- Can a common anesthesia drug shield the brain after heart surgery?